Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder)

Siegel, Matthew; McGuire, Kelly A.; Veenstra‐VanderWeele, Jeremy; Stratigos, Katharine; King, Bryan H.; Bellonci, Christopher; Hayek, Munya; Keable, Hélène; Rockhill, Carol; Bukstein, Oscar G.; Walter, Heather J.

doi:10.1016/j.jaac.2019.11.018

Cited by 30 publications

(37 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…PDD was the most common indication and accounted for a larger percentage of the antipsychotic prescribing in recent years. There is some evidence supporting use of antipsychotics in young children with PDD or intellectual disabilities for target symptoms or comorbid conditions 32,33 with some antipsychotics (risperidone and aripiprazole) having FDA approval for irritability associated with autism spectrum disorders for children as young as 5 years. In children with autism, pharmacotherapies, such as antipsychotics, may increase the benefits that children receive from behavioral and educational interventions.…”

Section: Discussionmentioning

confidence: 99%

Trends in Antipsychotic Medication Use in Young Privately Insured Children

Bushnell

Crystal

Olfson

2021

Journal of the American Academy of Child & Adolescent Psych

View full text Add to dashboard Cite

Objective: To estimate trends of annual antipsychotic medication use by privately insured young children (aged 2-7 years) in the United States, and to describe the clinical and treatment characteristics of these children. Method: The study population included young children from a nationwide commercial claims database (2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017). We estimated annual antipsychotic use by age and sex, defined as the number of children dispensed an antipsychotic per year divided by the number enrolled. We described clinical diagnoses and mental health service use in those with prescription antipsychotic use in 2009 and 2017. Results: Annual antipsychotic use in young children was 0.27% in 2007, peaked at 0.29% in 2009, and statistically significantly declined to 0.17% by 2017 (linear trend: À0.017% per year, 95% CI: À0.018 to À0.016). Antipsychotic use was higher in boys than in girls. A greater proportion of antipsychotic users received a mental disorder diagnosis in 2017 (89%) than in 2009 (86%, p < .01). The most common clinical diagnoses in antipsychotic users, under a hierarchical classification, were pervasive developmental disorder ( 2009

show abstract

Section: Discussionmentioning

confidence: 99%

Trends in Antipsychotic Medication Use in Young Privately Insured Children

Bushnell

Crystal

Olfson

2021

Journal of the American Academy of Child & Adolescent Psych

View full text Add to dashboard Cite

show abstract

“…Finally, considering that approximately 33% of the individuals with ASD have some form of intellectual disability [ 3 ], the choice to focus on high-functioning ASD may have excluded a substantial group of individuals with ASD. However, this choice allowed the exclusion of some clinical features, such as hyperkinesia or anxiety, which could be mainly related to the phenotype of intellectual disability [ 91 ]. Therefore, specific studies on the prevalence and distribution of psychiatric comorbidities in children with ASD and associated intellectual disability are necessary.…”

Section: Discussionmentioning

confidence: 99%

Psychiatric Comorbidities in Children and Adolescents with High-Functioning Autism Spectrum Disorder: A Study on Prevalence, Distribution and Clinical Features in an Italian Sample

Fucà

Guerrera

Valeri

et al. 2023

JCM

View full text Add to dashboard Cite

This study investigated the prevalence and distribution of psychiatric comorbidities in a group of 472 children and adolescents with ASD aged 3–18 years. We examined differences in age, sex, IQ, adaptive skills, and ASD symptom severity by comparing participants with ASD (ASD group) with participants with ASD and a psychiatric disorder (ASD/PSY group). Overall, 32.2% of participants had a comorbid psychiatric condition. Attention deficit/hyperactivity disorder (ADHD) was the most frequent diagnosis among preschoolers (20.4%); among school-age children, ADHD and anxiety/obsessive-compulsive disorders were the most frequent conditions (21% and 10.6%, respectively); finally, adolescents exhibit higher prevalence of anxiety/obsessive-compulsive disorders (21.8%). The ASD/PSY group showed a higher percentage of males, they were older and showed lower adaptive skills than the group with ASD; moreover, their mothers exhibited higher stress levels than mothers of participants in the ASD group. The comparison between age groups in participants within ASD/PSY group revealed that preschoolers had lower IQ than school-age children and adolescents, and worse adaptive skills, more repetitive behaviors, and restricted interests than adolescents. This study highlights the importance of an accurate diagnosis of psychiatric comorbidities in children and adolescents with ASD, also considering individual and family impairment.

show abstract

“…Additionally, the phenomenology of mental health symptoms differs in people with more severe intellectual disability, and adapted diagnostic manuals have been developed to assist clinicians (e.g., Diagnostic Manual Intellectual Disability; DM-ID-2 25 ). Siegel et al 26 recently published practice guidelines for the assessment of mental health problems in children with intellectual disability.…”

Section: Diagnosing Mental Health Disorders In Children With Intellec...mentioning

confidence: 99%